These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 20516559)

  • 21. Resistance of hepatitis B virus to antiviral drugs: current aspects and directions for future investigation.
    Delaney WE; Locarnini S; Shaw T
    Antivir Chem Chemother; 2001 Jan; 12(1):1-35. PubMed ID: 11437320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Substitution at rt269 in Hepatitis B Virus Polymerase Is a Compensatory Mutation Associated with Multi-Drug Resistance.
    Ahn SH; Kim DH; Lee AR; Kim BK; Park YK; Park ES; Ahn SH; Shin GC; Park S; Kang HS; Rhee JK; Yang SI; Chong Y; Kim KH
    PLoS One; 2015; 10(8):e0136728. PubMed ID: 26322642
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New treatment of chronic hepatitis B.
    Lok AS
    Semin Liver Dis; 2004; 24 Suppl 1():77-82. PubMed ID: 15192805
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular modeling and biochemical characterization reveal the mechanism of hepatitis B virus polymerase resistance to lamivudine (3TC) and emtricitabine (FTC).
    Das K; Xiong X; Yang H; Westland CE; Gibbs CS; Sarafianos SG; Arnold E
    J Virol; 2001 May; 75(10):4771-9. PubMed ID: 11312349
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evolution and suppression of HBV strains with multidrug resistance to lamivudine, adefovir dipivoxil and entecavir in a patient with chronic hepatitis B.
    Liu Y; Wang C; Zhong Y; Chen L; Li X; Ji D; Wang H; Xin S; Zoulim F; Xu D
    Antivir Ther; 2010; 15(8):1185-90. PubMed ID: 21149926
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis B in HIV patients: what is the current treatment and what are the challenges?
    Soriano V; Tuma P; Vispo E; Labarga P; Fernández JV; Medrano J; Barreiro P
    J HIV Ther; 2009 Mar; 14(1):13-8. PubMed ID: 19731560
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Meta-analysis: oral anti-viral agents in adults with decompensated hepatitis B virus cirrhosis.
    Singal AK; Fontana RJ
    Aliment Pharmacol Ther; 2012 Mar; 35(6):674-89. PubMed ID: 22257108
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis B virus treatment in HIV-infected patients.
    Thio CL
    Top HIV Med; 2006 Dec-2007 Jan; 14(5):170-5. PubMed ID: 17237559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Resistance in hepatitis B virus].
    Sheldon J; Sarmento E Castro R; Soriano V
    Enferm Infecc Microbiol Clin; 2008 May; 26 Suppl 7():49-55. PubMed ID: 19100231
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extrahepatic effects of nucleoside and nucleotide analogues in chronic hepatitis B treatment.
    Fung J; Seto WK; Lai CL; Yuen MF
    J Gastroenterol Hepatol; 2014 Mar; 29(3):428-34. PubMed ID: 24372662
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trends in hepatitis B virus resistance to nucleoside/nucleotide analogues in North China from 2009-2016: A retrospective study.
    Guo X; Wu J; Wei F; Ouyang Y; Li Q; Liu K; Wang Y; Zhang Y; Chen D
    Int J Antimicrob Agents; 2018 Aug; 52(2):201-209. PubMed ID: 29654894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Telbivudine exhibits no inhibitory activity against HIV-1 clinical isolates in vitro.
    Lin K; Karwowska S; Lam E; Limoli K; Evans TG; Avila C
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2670-3. PubMed ID: 20308377
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of a novel mouse model to evaluate drug candidates against hepatitis B virus.
    Feitelson MA; Clayton MM; Sun B; Schinazi RF
    Antivir Chem Chemother; 2007; 18(4):213-23. PubMed ID: 17907379
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of the replication of the DNA polymerase M550V mutation variant of human hepatitis B virus by adefovir, tenofovir, L-FMAU, DAPD, penciclovir and lobucavir.
    Ying C; De Clercq E; Nicholson W; Furman P; Neyts J
    J Viral Hepat; 2000 Mar; 7(2):161-5. PubMed ID: 10760047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [New drugs of treatment of patients with chronic hepatitis B].
    Suzuki F
    Nihon Rinsho; 2012 Apr; 70(4):660-3. PubMed ID: 22568150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The efficacy of adefovir dipivoxil, entecavir and telbivudine for chronic hepatitis B treatment: a systematic review].
    Almeida AM; Ribeiro AQ; Pádua CA; Brandão CM; Andrade EI; Cherchiglia ML; Carmo RA; Acurcio Fde A
    Rev Soc Bras Med Trop; 2010; 43(4):440-51. PubMed ID: 20802947
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro characterization of the anti-hepatitis B virus activity and cross-resistance profile of 2',3'-dideoxy-3'-fluoroguanosine.
    Jacquard AC; Brunelle MN; Pichoud C; Durantel D; Carrouée-Durantel S; Trepo C; Zoulim F
    Antimicrob Agents Chemother; 2006 Mar; 50(3):955-61. PubMed ID: 16495257
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generation of a human hepatoma cell line supporting efficient replication of a lamivudine resistant hepatitis B virus.
    Zhang Y; Zhang Y; Kang Y; Wang J; Liu H; Zhu H; Qin Y; Mao R; Lin X; Lu M; Zhang J
    J Virol Methods; 2014 Jun; 201():51-6. PubMed ID: 24583110
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro susceptibilities of wild-type or drug-resistant hepatitis B virus to (-)-beta-D-2,6-diaminopurine dioxolane and 2'-fluoro-5-methyl-beta-L-arabinofuranosyluracil.
    Chin R; Shaw T; Torresi J; Sozzi V; Trautwein C; Bock T; Manns M; Isom H; Furman P; Locarnini S
    Antimicrob Agents Chemother; 2001 Sep; 45(9):2495-501. PubMed ID: 11502520
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical management of patients with chronic hepatitis B virus infection].
    Rodríguez M; González-Diéguez ML
    Enferm Infecc Microbiol Clin; 2008 May; 26 Suppl 7():56-65. PubMed ID: 19100232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.